Loading
Latest filing published 17 Nov 2023 for OMEROS CORP, €14k.
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Peter A. Demopulos MD in Omeros Corp. Over a trading history stretching from 13 October 2009 to 15 November 2023, the count stands at 14 filings.
Every open-market trade on record is a purchase: 7 purchases worth €431k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 5 option exercises. 2023 to date brings 1 purchase and no sales.
In size, the median ticket on the buying side is €67k. After 7 purchases with a full 90-day history, the hit rate stands at 29% and the median 90-day move at -24.0%. Past outcomes like these are no guarantee of what comes next.
The latest filing, published on 17 November 2023, reports an open-market purchase of €14k in Omeros Corp. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations